Fogo de Chão Announces Plans to Enter Canada
DALLAS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Fogo de Chão, the internationally-renowned restaurant from Brazil that allows guests to make discoveries at every turn, today announced the signing of a ...
DALLAS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Fogo de Chão, the internationally-renowned restaurant from Brazil that allows guests to make discoveries at every turn, today announced the signing of a ...
New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise Second collaboration with AbbVie follows 2020 agreement focused on inflammatory and autoimmune diseasesSosei Heptares ...
Boerne, Texas, July 22, 2022 (GLOBE NEWSWIRE) -- It’s the Dog Days of Summer, no bones about it! Here’s a tip for how to plan a trip and beat the ...
ENGLEWOOD, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) is pleased to announce a new fuel sales agreement with Finnair. The Agreement outlines the details for the ...
OneRare is thrilled to announce its partnership with renowned Chef and Food Blogger, Nehal Karkera, as he sets foot in OneRare's Foodverse. Nehal, a professional chef from Mumbai, India, loves ...
Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors, from its fill and finish facility in Stein, SwitzerlandPierre Fabre ...
HANOI, Vietnam, June 06, 2022 (GLOBE NEWSWIRE) -- 4th June, 2022, the Vietnam Blockchain Association and Binance - the world's leading Blockchain development technology corporation - officially announced their cooperation ...
MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical ...
NEW HAVEN, CONN., U.S.A., May 10, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC.. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”) a biopharmaceutical company developing its proprietary xB3TM platform technology for the ...
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to $90.5 millionMyovant also eligible to receive tiered royalties from the ...